Research confirms the power of marijuana in pain management and treating substance abuse. Big Pharma should be worried. Read More

These mega-cap tech stocks account for about 60% of the S&P 500's strong rise over the past 12 months. Can the seven stay in the saddle? Read More

Leverage can be useful, if applied properly. Here’s a look at certain types of loans that are rip-offs. Read More

Jobs growth and tech profits paint a rosy, not red-hot, picture. We parse the latest economic data. Read More

Nike's revised guidance for this year caught Wall Street off guard, paving the way for a very profitable trade. Read More

It pays to keep an eye on the bond market, which represents a collective wisdom about the future direction of not just bonds but also stocks. Read More

Despite the rise of a wide variety of new cannabis products, the most popular form remains traditional, smokeable flower. Read More

The focus will now be on any hint of a rate cut as soon as possible after March. Read More

As expected, the U.S. central bank Wednesday kept interest rates on hold at 5.25% - 5.50%. Now, all eyes are on the timing of future cuts. Read More

It may seem counter-intuitive, but often the correct investment decision is to average up. Here's why. Read More